首页|血小板/淋巴细胞比值、预后营养指数、细胞角质蛋白19片段抗原21-1与胸腺瘤患者临床特征及预后的关系

血小板/淋巴细胞比值、预后营养指数、细胞角质蛋白19片段抗原21-1与胸腺瘤患者临床特征及预后的关系

扫码查看
目的 探讨血小板/淋巴细胞比值(PLR)、预后营养指数(PNI)、细胞角质蛋白19片段抗原21-1(CYR-FA21-1)与胸腺瘤患者临床特征及预后的关系.方法 选取125例胸腺瘤患者作为观察组,另选取116例健康体检者作为对照组,比较两组受试者及不同临床特征胸腺瘤患者PLR、PNI、CYFRA21-1.对胸腺瘤患者随访1年,根据预后情况分为预后良好组和预后不良组,比较不同预后胸腺瘤患者的临床特征,并采用多元Logistic回归模型分析胸腺瘤患者预后的影响因素.结果 观察组患者PLR、PNI及CYFRA21-1均明显高于对照组,差异均有统计学意义(P<0.01).不同组织学类型、Masaoka分期、肿瘤直径胸腺瘤患者PLR、CYFRA21-1比较,差异均有统计学意义(P<0.01);不同组织学类型、Masaoka分期胸腺瘤患者PNI比较,差异均有统计学意义(P<0.05).预后良好组(n=98)和预后不良组(n=27)患者组织学类型、Masaoka分期、PLR、PNI、CYFRA21-1比较,差异均有统计学意义(P<0.01).多因素Logistic回归分析结果显示,组织学类型、Masaoka分期、PLR、PNI、CYFRA21-1均是胸腺瘤患者预后的影响因素(P<0.05).结论 PLR、PNI、CYFRA21-1在胸腺瘤中高表达,与患者的临床特征有关,是胸腺瘤患者预后的影响因素.
Relationship between platelet-to-lymphocyte ratio,prognostic nutritional index,cyto-keratin 19 fragment antigen 21-1 and clinical characteristics and prognosis of patients with thymoma
Objective To investigate the relationship between platelet-to-lymphocyte ratio(PLR),prognostic nutri-tional index(PNI),cyto-keratin 19 fragment antigen 21-1(CYRFA21-1)and clinical characteristics and prognosis of pa-tients with thymoma.Method A total of 125 thymoma patients were selected as the observation group and 116 healthy subjects were selected as the control group.The PLR,PNI and CYFRA21-1 were compared between the two groups and thymoma patients with different clinical characteristics.The thymoma patients were followed up for one year and divided into good prognosis group and poor prognosis group according to the prognosis.The clinical characteristics of thymoma patients with different prognosis were compared,and the influencing factors on prognosis of thymoma patients were ana-lyzed by multiple Logistic regression model.Result The PLR,PNI and CYFRA21-1 in observation group were signifi-cantly higher than those in control group,and the differences were statistically significant(P<0.01).The PLR and CY-FRA21-1 of thymoma patients with different histological types,Masaoka stages and tumor diameters were compared,and the differences were statistically significant(P<0.01).The PNI of thymoma patients with different histological types and Masaoka stages were compared,and the differences were statistically significant(P<0.05).The histological type,Masao-ka stage,PLR,PNI and CYFRA21-1 in good prognosis group(n=98)and poor prognosis group(n=27)were compared,and the differences were statistically significant(P<0.01).Multivariate Logistic regression analysis showed that histologi-cal type,Masaoka stage,PLR,PNI and CYFRA21-1 were influencing factors on prognosis of thymoma patients(P<0.05).Conclusion PLR,PNI,and CYFRA21-1 are highly expressed in thymoma,which are related to the clinical char-acteristics of patients and are influencing factors on prognosis of thymoma patients.

thymomaplatelet-to-lymphocyte ratioprognostic nutritional indexcyto-keratin 19 fragment antigen 21-1clinical characteristicprognosis

王总飞、易昌盛、钱鑫、申思宁、郑燕、刘奇、邢文群

展开 >

郑州大学附属肿瘤医院/河南省肿瘤医院胸外科,郑州 450000

胸腺瘤 血小板/淋巴细胞比值 预后营养指数 细胞角质蛋白19片段抗原21-1 临床特征 预后

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(9)